手术治疗结直肠癌腹膜转移75 例预后分析
钟清华， 马腾辉， 王怀明， 刘俊杰， 黄斌杰， 袁紫旭… - 中国实用外科 …, 2016 - zgsyz.com
目的探讨影响结直肠癌腹膜转移手术疗效的预后因素. 方法回顾性分析中山大学附属第六医院
2011 年1 月至2015 年1 月行手术治疗的75 例结直肠癌腹膜转移病人的临床及随访资料 …
2011 年1 月至2015 年1 月行手术治疗的75 例结直肠癌腹膜转移病人的临床及随访资料 …
[HTML][HTML] Do we still need CRS and HIPEC in colorectal cancer in times of modern chemotherapy and immunotherapy?
E Gasser, P Kogler, A Lorenz, R Kafka-Ritsch… - Memo-Magazine of …, 2020 - Springer
Peritoneal carcinomatosis from colorectal cancer is associated with a poor prognosis and is
usually treated with systemic chemotherapy and immunotherapy alone. In patients with …
usually treated with systemic chemotherapy and immunotherapy alone. In patients with …
External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic …
M Tonello, D Baratti, P Sammartino, A Di Giorgio… - European Journal of …, 2023 - Elsevier
Introduction The selection of patients undergoing cytoreductive-surgery (CRS) followed by
hyperthermic intraperitoneal chemotherapy (HIPEC) is crucial. BIOSCOPE and COMPASS …
hyperthermic intraperitoneal chemotherapy (HIPEC) is crucial. BIOSCOPE and COMPASS …
Biomarkers in the management of peritoneal metastases
N Katdare, A Bhatt, O Glehen - Pathology of Peritoneal Metastases: The …, 2020 - Springer
Selected patients with peritoneal metastases are treated with a curative intent, the backbone
of which is cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal …
of which is cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal …
结直肠癌腹膜转移治疗的基础与临床研究.
田铭锒， 黄磊， 梅秀升， 刘洋， 高源… - Journal of Modern …, 2023 - search.ebscohost.com
在中国, 结直肠癌(CRC) 发病率在各癌种中位于第2 位, 死亡率在各癌种中位于第4 位. 其中5%~
15% 的CRC 患者会发生同时性腹膜转移(PM), 约20% 会发生异时性PM. CRCPM 是位于肝 …
15% 的CRC 患者会发生同时性腹膜转移(PM), 约20% 会发生异时性PM. CRCPM 是位于肝 …
[HTML][HTML] A Simplified Peritoneal Sarcomatosis Score for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
SA Naffouje, KA Tulla, GI Salti - Journal of Gastrointestinal …, 2018 - ncbi.nlm.nih.gov
Background With the introduction of cytoreductive surgery (CRS) and hyperthermic
intraperitoneal chemotherapy (HIPEC), long-term survival can be achieved in selected …
intraperitoneal chemotherapy (HIPEC), long-term survival can be achieved in selected …
Incidence, risk factors, and outcomes of the transition of HIPEC-induced acute kidney injury to acute kidney disease: a retrospective study
Y Lu, Z Xiao, X Zhao, Y Ye, S Li, F Guo, H Xue… - Renal Failure, 2024 - Taylor & Francis
Background Acute kidney injury (AKI) is recognized as a common complication following
cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS …
cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS …
[PDF][PDF] Primary curative surgery and preemptive or adjuvant hyperthermic peritoneal chemotherapy in colorectal cancer patients at high risk to develop peritoneal …
Purpose: Τo evaluate all available data on the effect of preemptive intervention in patients
who have curative surgery for colorectal cancer (CRC) and are at high risk to develop …
who have curative surgery for colorectal cancer (CRC) and are at high risk to develop …
Cytoreductive surgery and HIPEC in the first-line and interval time points of advanced epithelial ovarian cancer
S Kusamura, S Sinukumar, D Baratti, M Guaglio… - Indian Journal of …, 2017 - Springer
The increasing popularity of cytoreductive surgery (CRS) and hyperthermic intraperitoneal
chemotherapy (HIPEC) for epithelial ovarian cancer (EOC) has been focus of a heated …
chemotherapy (HIPEC) for epithelial ovarian cancer (EOC) has been focus of a heated …
[PDF][PDF] Peritoneal metastases: challenges for the surgeon
D Baratti, S Kusamura, M Guaglio, M Deraco - Minerva Chir, 2015 - researchgate.net
MINERVA MEDICA COPYRIGHT® Page 1 Vol. 70 - No. 3 MINERVA CHIRURGICA 195
peritoneum based neoplasms, such as diffuse malignant peritoneal mesothelioma, and primary …
peritoneum based neoplasms, such as diffuse malignant peritoneal mesothelioma, and primary …